These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6454812

  • 1. [Therapeutic value of colchicine in Behçhet's disease (author's transl)].
    Moreno Moraga J, Estrada Saiz RV, Chantres Antoranz MT, Rivas Flores J, Gilsanz García V.
    Med Clin (Barc); 1981 Jun 10; 77(1):18-20. PubMed ID: 6454812
    [Abstract] [Full Text] [Related]

  • 2. [Antigen HLA-B5 in Adamantiadès-Behçet syndrome (author's transl)].
    Psilas K, Polymenidis Z, Georgiadès G.
    J Fr Ophtalmol; 1979 Dec 10; 2(12):701-4. PubMed ID: 536572
    [Abstract] [Full Text] [Related]

  • 3. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
    Hazen PG, Michel B.
    Arch Dermatol; 1979 Nov 10; 115(11):1303-6. PubMed ID: 507883
    [Abstract] [Full Text] [Related]

  • 4. [Colchicine in the treatment of Behçet's disease (author's transl)].
    Mizushima Y, Matsumura N, Mori M, Matsumura Y, Shimizu T, Fukushima B, Mimura Y, Saito K, Sugiura S, Yamana S, Miyake S, Urayama A, Tanaka Y, Miyoshi K, Shirakami A.
    Ryumachi; 1978 Mar 10; 18(2):112-6. PubMed ID: 663792
    [No Abstract] [Full Text] [Related]

  • 5. [Pustular vasculitis disclosing Behçet disease].
    Castanet J, Carmignani S, Lacour JP, Perrin C, Lagrange B, Dor JF, Ortonne JP.
    Ann Dermatol Venereol; 1994 Mar 10; 121(9):629-31. PubMed ID: 7771731
    [Abstract] [Full Text] [Related]

  • 6. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
    Lehner T, Welsh KI, Batchelor JR.
    Immunology; 1982 Dec 10; 47(4):581-7. PubMed ID: 6958639
    [Abstract] [Full Text] [Related]

  • 7. Number VII Behçet's disease (Adamantiades syndrome).
    Escudier M, Bagan J, Scully C.
    Oral Dis; 2006 Mar 10; 12(2):78-84. PubMed ID: 16476027
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of Behçet's syndrome with colchicine].
    Pacor ML, Nicolis F, Peroli P, Urbani G, Cortina P, Corrocher R, Lunardi C.
    Riv Eur Sci Med Farmacol; 1989 Jun 10; 11(3):257-61. PubMed ID: 2640046
    [Abstract] [Full Text] [Related]

  • 9. [Behçet's disease. II. Etiopathogenetic and therapeutic aspects. Personal observations].
    Lovisetto P, Monteverde A, Cargnino M, Cadario G, Biarese V, Marchi L, Catania E.
    Minerva Med; 1984 Oct 13; 75(39):2263-82. PubMed ID: 6334250
    [Abstract] [Full Text] [Related]

  • 10. [Behcet's disease and joint affection].
    Alekberova ZS, Elonakov AV, Goloeva RG, Smirnov AV, Guseva IA, Nasonov EL.
    Ter Arkh; 2008 Oct 13; 80(5):56-8. PubMed ID: 18590116
    [Abstract] [Full Text] [Related]

  • 11. [Behçet's syndrome with amyloidosis. Report of a case. Clinical remission with colchicine].
    Hamza M, Ben Maiz H, Ayed K, Ben Ayed H.
    Rev Rhum Mal Osteoartic; 1980 Jun 13; 47(6):431-3. PubMed ID: 7455603
    [No Abstract] [Full Text] [Related]

  • 12. [Behcet's disease therapy review].
    Vidaller Palacín A, Robert Olalla J, Sanuy Jiménez B, Rufi Rigau G, Folch Civit J, Charte González A.
    An Med Interna; 2002 Nov 13; 19(11):594-8. PubMed ID: 12522899
    [Abstract] [Full Text] [Related]

  • 13. [The relationship of the HLA antigen system to Behçet's disease].
    Golosenko IIu.
    Vestn Dermatol Venerol; 1990 Nov 13; (5):55-7. PubMed ID: 2402945
    [Abstract] [Full Text] [Related]

  • 14. [Association of agramulocytosis caused by levamisole and HLA B27 in Behçet's disease].
    Hamza M, Ben Ayed H.
    Nouv Presse Med; 1979 Oct 15; 8(39):3167-8. PubMed ID: 537876
    [No Abstract] [Full Text] [Related]

  • 15. A child with Behçet's disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis.
    Pektaş A, Devrim I, Beşbaş N, Bilginer Y, Cengiz AB, Ozen S.
    Turk J Pediatr; 2008 Oct 15; 50(1):78-80. PubMed ID: 18365598
    [Abstract] [Full Text] [Related]

  • 16. Use of colchicine in Behçet's syndrome.
    Sander HM, Randle HW.
    Cutis; 1986 May 15; 37(5):344-8. PubMed ID: 3519102
    [Abstract] [Full Text] [Related]

  • 17. [HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].
    Djawari D, Lang B, Hornstein OP.
    Z Hautkr; 1984 Aug 01; 59(15):1005-9. PubMed ID: 6485449
    [Abstract] [Full Text] [Related]

  • 18. Major arterial involvement and review of Behcet's disease.
    Alpagut U, Ugurlucan M, Dayioglu E.
    Ann Vasc Surg; 2007 Mar 01; 21(2):232-9. PubMed ID: 17349371
    [Abstract] [Full Text] [Related]

  • 19. The high prevalence of HLA-B5 in Behçet's disease.
    Yazici H, Akokan G, Yalçin B, Müftüoğlu A.
    Clin Exp Immunol; 1977 Nov 01; 30(2):259-61. PubMed ID: 606446
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of Behçet's disease with immunosuppressive agents and colchicine (author's transl)].
    Kadoya M, Okinami S.
    Nippon Ganka Gakkai Zasshi; 1979 Mar 01; 83(3):200-6. PubMed ID: 484365
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.